247 related articles for article (PubMed ID: 16207305)
41. Absorption of enrofloxacin and marbofloxacin after oral and subcutaneous administration in diseased koalas (Phascolarctos cinereus).
Griffith JE; Higgins DP; Li KM; Krockenberger MB; Govendir M
J Vet Pharmacol Ther; 2010 Dec; 33(6):595-604. PubMed ID: 21062313
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in the Korean catfish (Silurus asotus).
Park BK; Lim JH; Kim MS; Yun HI
J Vet Pharmacol Ther; 2006 Feb; 29(1):37-40. PubMed ID: 16420300
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics and lung-targeting characterization of a newly formulated enrofloxacin preparation.
Tang S; Zhou Y; Li R; Chen Q; Xiao X
J Vet Pharmacol Ther; 2007 Oct; 30(5):443-50. PubMed ID: 17803737
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats.
Elmas M; Tras B; Kaya S; Bas AL; Yazar E; Yarsan E
Can J Vet Res; 2001 Jan; 65(1):64-7. PubMed ID: 11227198
[TBL] [Abstract][Full Text] [Related]
46. Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration.
Boothe DM; Boeckh A; Boothe HW; Wilkie S
Vet Ther; 2001; 2(2):120-8. PubMed ID: 19753704
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of diclofenac and its interaction with enrofloxacin in sheep.
Rahal A; Kumar A; Ahmad AH; Malik JK
Res Vet Sci; 2008 Jun; 84(3):452-6. PubMed ID: 17692878
[TBL] [Abstract][Full Text] [Related]
49. Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline.
Conte JE; Golden JA; Kelly MG; Zurlinden E
Int J Antimicrob Agents; 2005 Jun; 25(6):523-9. PubMed ID: 15885987
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic-pharmacodynamic integration of orbifloxacin in Japanese quail (Coturnix japonica) following oral and intravenous administration.
Hawkins MG; Taylor IT; Byrne BA; Armstrong RD; Tell LA
J Vet Pharmacol Ther; 2011 Aug; 34(4):350-8. PubMed ID: 20950349
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics of erythromycin after the administration of intravenous and various oral dosage forms to dogs.
Albarellos GA; Kreil VE; Ambros LA; Waxman S; Montoya L; Tarragona L; Quaine PC; Hallu RE; Rebuelto M
J Vet Pharmacol Ther; 2008 Dec; 31(6):496-500. PubMed ID: 19000270
[TBL] [Abstract][Full Text] [Related]
52. Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction.
Peyrou M; Bousquet-Melou A; Laroute V; Vrins A; Doucet MY
J Vet Pharmacol Ther; 2006 Oct; 29(5):337-44. PubMed ID: 16958777
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration to ostriches.
de Lucas JJ; Rodríguez C; Waxman S; González F; Uriarte I; San Andrés MI
Vet J; 2005 Nov; 170(3):364-8. PubMed ID: 16266851
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats.
Albarellos GA; Ambros LA; Landoni MF
J Vet Pharmacol Ther; 2005 Aug; 28(4):363-9. PubMed ID: 16050816
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetic behavior of enrofloxacin and its metabolite ciprofloxacin in urutu pit vipers (Bothrops alternatus) after intramuscular administration.
Waxman S; Prados AP; de Lucas JJ; San Andrés MI; Regner P; de Oliveira VC; de Roodt A; Rodríguez C
J Zoo Wildl Med; 2014 Mar; 45(1):78-85. PubMed ID: 24712165
[TBL] [Abstract][Full Text] [Related]
56. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetic-pharmacodynamic integration of orbifloxacin in rabbits after intravenous, subcutaneous and intramuscular administration.
Marín P; Fernández-Varón E; Escudero E; Vancraeynest D; Cárceles CM
J Vet Pharmacol Ther; 2008 Feb; 31(1):77-82. PubMed ID: 18177323
[TBL] [Abstract][Full Text] [Related]
58. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
Batzias GC; Delis GA; Athanasiou LV
Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics of mequindox and one of its major metabolites in chickens after intravenous, intramuscular and oral administration.
Ding H; Liu Y; Zeng Z; Si H; Liu K; Liu Y; Yang F; Li Y; Zeng D
Res Vet Sci; 2012 Aug; 93(1):374-7. PubMed ID: 21839487
[TBL] [Abstract][Full Text] [Related]
60. Influence of Pasteurella multocida infection on the pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in rabbits.
Abo-el-Sooud K; Goudah A
J Vet Pharmacol Ther; 2010 Feb; 33(1):63-8. PubMed ID: 20444027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
